Rikke L. Eefsen
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.
Journal: Journal for immunotherapy of cancer
Published: June 29, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 27, 2026
Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.
Journal: Cancer research communications
Published: March 10, 2026
Remission of metastatic duodenal cancer after treatment with BRAF inhibitor
Journal: Ugeskrift for laeger
Published: January 30, 2026
Real-world outcomes of pembrolizumab in advanced anal cancer: a nationwide Danish anal Cancer Group report.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 03, 2025
Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2025
A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.
Journal: BMC cancer
Published: June 15, 2025
Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor survival in advanced pancreatic cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 21, 2025
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma.
Journal: Immuno-oncology technology
Published: January 13, 2025
Long-Term Data From Patients Who Received Pembrolizumab in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma.
Journal: Case reports in oncological medicine
Published: September 24, 2024
Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.
Journal: Cell reports. Medicine
Published: August 29, 2024
Last Updated: 09/26/2026